Medically reviewed by a licensed clinician. Last updated April 2026.

The GLP-1 weight loss market has exploded over the past two years, and so has the number of clinics trying to capitalize on demand. Most are legitimate medical practices staffed by licensed, qualified providers. But a meaningful number are not. Some cut corners on medical oversight. Others source medications from unregulated suppliers. A few are outright scams.

:::takeaway

  • The FDA has issued approximately 30 warning letters to telehealth companies and pharmacies selling GLP-1 medications improperly.
  • Red flags include no verifiable NPI number, no follow-up appointments, suspiciously low prices, and medications from unverified compounding pharmacies.
  • Green flags include NPI-verified providers, ABOM certification, FDA-approved medications, transparent pricing, and structured follow-up protocols.
  • Every patient should verify their provider's credentials independently before starting treatment.

:::

The FDA has taken notice. As of early 2026, the agency has sent approximately 30 warning letters to telehealth companies and compounding pharmacies for violations ranging from selling unapproved semaglutide products to making false efficacy claims. This is a real problem, and patients need practical tools to protect themselves.

This guide gives you a concrete checklist for evaluating any GLP-1 clinic, whether it is a brick-and-mortar practice down the street or a telehealth platform you found through an Instagram ad.

Red Flags: Warning Signs of an Unsafe Clinic

The following warning signs should give you serious pause. Any single red flag warrants further investigation. Multiple red flags together should send you elsewhere.

1. No Verifiable NPI Number

Every legitimate healthcare provider in the United States has a National Provider Identifier (NPI) number. This is a unique 10-digit number issued by CMS. If a clinic or provider cannot give you their NPI, or if the number they provide does not match their name on the NPPES NPI Registry, that is a fundamental credibility problem.

2. No Medical License Verification

Licensed physicians, nurse practitioners, and physician assistants must hold active state medical licenses. These are publicly searchable through each state's medical board website. If a clinic cannot or will not tell you the name and credentials of the provider who will be prescribing your medication, treat that as a serious warning.

3. Prices That Seem Too Good to Be True

Compounded semaglutide generally costs $149 to $349 per month from reputable sources. If a clinic is advertising GLP-1 treatment for $49 per month or similarly dramatic discounts, ask yourself what is being cut to hit that price point. Common cost-cutting tactics include using substandard compounding sources, underdosing medications, providing no medical oversight, or charging hidden fees that appear later.

4. No Follow-Up Appointments

GLP-1 medications require dose titration over several months. They also carry real side effects that need monitoring. Any clinic that writes a prescription and does not schedule follow-up visits is not practicing medicine safely. A legitimate treatment plan includes check-ins at minimum every 4 weeks during the titration phase.

5. Compounding From Unverified Pharmacies

Not all compounding pharmacies are created equal. FDA-registered 503B outsourcing facilities are subject to regular inspections, must follow current Good Manufacturing Practices (cGMP), and are held to higher safety standards. If a clinic sources medications from a 503A compounding pharmacy or an unregistered entity, the risk of contamination, incorrect dosing, or substandard formulation increases.

Ask the clinic directly: "Where is the medication compounded, and is that pharmacy registered as a 503B outsourcing facility with the FDA?"

6. No Prescriber Name Provided

You have the right to know who is prescribing your medication. If a clinic tells you that a "medical team" will review your case but cannot provide a specific prescriber's name and credentials, that is a transparency problem. In some cases, this structure is used to obscure the fact that prescriptions are being rubber-stamped without meaningful clinical review.

7. Aggressive or Misleading Marketing

Claims like "guaranteed to lose 30 pounds in 30 days," "no side effects," or "works for everyone" are not just marketing exaggerations. They are violations of FDA regulations on drug advertising. Legitimate clinics describe realistic outcomes and acknowledge that results vary. Clinics that promise the impossible are more likely to cut corners in other areas.

For more on what makes a provider trustworthy, visit our methodology page and our guide on how to find a legitimate GLP-1 provider.

Green Flags: Signs of a Legitimate Clinic

These are the markers of a clinic that is doing things right.

1. NPI-Verified Providers

The prescribing provider has an active, verifiable NPI number that matches their name and credentials on the NPPES registry. The clinic is willing to share this information proactively.

2. Active State Medical License

The provider holds a current, unrestricted medical license in the state where they are practicing or where you reside (for telehealth). You can verify this yourself through the state medical board's website.

3. ABOM Certification (Bonus, Not Required)

Physicians certified by the American Board of Obesity Medicine have completed additional training in obesity science and pharmacotherapy. While ABOM certification is not required to prescribe GLP-1 medications, it indicates a higher level of specialization. You can search the ABOM diplomate directory at abom.org.

4. FDA-Approved Medications or Verified 503B Compounding

The clinic either prescribes FDA-approved brand-name medications (Wegovy, Zepbound, Mounjaro, Ozempic) or sources compounded medications from FDA-registered 503B outsourcing facilities. They can tell you the name of the pharmacy and provide documentation if asked.

5. Transparent Pricing

The total cost of treatment, including consultations, medication, shipping, and follow-up visits, is clearly stated before you commit. There are no hidden fees, surprise charges, or bait-and-switch pricing where the advertised rate only applies to the first month.

6. Structured Follow-Up Protocol

The clinic schedules regular follow-up appointments as part of the standard treatment plan. During titration (the first 3 to 4 months), check-ins should happen every 4 weeks. After reaching your maintenance dose, follow-ups every 8 to 12 weeks are standard. The clinic tracks your progress, adjusts doses as needed, and monitors for side effects.

7. Comprehensive Intake Process

Legitimate clinics ask detailed questions about your medical history, current medications, allergies, and previous weight loss attempts. They order or review recent lab work. If a provider is willing to prescribe GLP-1 medication based on a 2-minute questionnaire with no medical history review, the quality of care is likely inadequate.

The FDA's Enforcement Actions

The FDA has escalated enforcement against GLP-1 market abuses throughout 2025 and into 2026. Here is what the agency has targeted.

Warning Letters to Telehealth Companies

Approximately 30 warning letters have been issued to companies selling GLP-1 products that were unapproved, misbranded, or marketed with false claims. Common violations include selling "semaglutide" products that do not contain the correct active ingredient or concentration, marketing compounded medications as equivalent to FDA-approved products, and making disease treatment claims without appropriate evidence.

Compounding Pharmacy Enforcement

The FDA has also taken action against compounding pharmacies that failed to meet manufacturing standards. In several cases, inspections revealed contamination risks, inadequate sterility testing, and improper storage conditions. These enforcement actions underscore why patients should confirm that their medication comes from a 503B outsourcing facility with a clean inspection record.

What This Means for Patients

FDA enforcement is a positive development for patient safety. But the agency cannot inspect every clinic and pharmacy, especially in a market growing this fast. The responsibility to verify your provider ultimately rests with you. The checklist below is your tool for doing exactly that.

For a deeper look at GLP-1 safety concerns, see our safety page.

Your Verification Checklist

Use this checklist before committing to any GLP-1 clinic or telehealth platform. You should be able to answer "yes" to every item.

Provider Credentials

  • The prescribing provider's full name and credentials are disclosed.
  • The provider has an active NPI number verified on npiregistry.cms.hhs.gov.
  • The provider holds a current medical license in the relevant state, verified through the state medical board.

Medication Safety

  • The clinic discloses which specific medication(s) they prescribe (brand-name, compounded, or both).
  • If compounded, the pharmacy is an FDA-registered 503B outsourcing facility.
  • The medication arrives with proper labeling including the pharmacy name, active ingredient, concentration, and expiration date.

Treatment Protocol

  • The intake process includes a thorough medical history review.
  • Lab work is required or reviewed before prescribing.
  • Follow-up appointments are scheduled as part of the standard treatment plan.
  • The clinic has a clear process for dose adjustments and managing side effects.

Pricing and Transparency

  • Total treatment costs are disclosed upfront, including consultations, medication, and shipping.
  • There are no hidden fees or surprise charges after enrollment.
  • Cancellation and refund policies are clearly stated.

Communication

  • You can reach your provider or care team between scheduled visits (via messaging, phone, or portal).
  • The clinic provides clear instructions on what to do if you experience side effects.
  • Emergency contact information or guidance is available for urgent concerns.

How to Verify: Step by Step

If you want to verify a clinic right now, here is the process.

Step 1: Get the provider's name. Ask the clinic who will be prescribing your medication. If they will not tell you, stop here.

Step 2: Search the NPI Registry. Go to npiregistry.cms.hhs.gov and search by the provider's name. Confirm their NPI is active and their specialty aligns with weight management.

Step 3: Check the state medical board. Search the relevant state medical board website for the provider's license. Confirm it is active, unrestricted, and free of disciplinary actions.

Step 4: Verify the compounding pharmacy (if applicable). Ask for the pharmacy name and search the FDA's 503B Outsourcing Facility database at fda.gov. Confirm registration and check for any recent inspection findings.

Step 5: Read independent reviews. Check Google Reviews, Healthgrades, and our directory at glp1clinics.org/glp1-clinics for patient feedback. Look for patterns, not just individual reviews.

The Bottom Line

The GLP-1 market is delivering real results for millions of patients. But its rapid growth has also attracted providers who prioritize revenue over patient safety. You do not need to be paranoid, but you do need to be informed.

Verifying a clinic takes about 15 minutes. Check the NPI. Check the medical license. Ask about the pharmacy. Confirm that follow-up care is included. These simple steps separate the legitimate providers from the ones cutting corners.

If a clinic resists transparency on any of these points, that tells you everything you need to know. Move on. There are plenty of qualified, ethical providers who will earn your trust with openness, not evasion.

:::info

GLP-1 medications require a prescription and ongoing medical supervision. Always work with a licensed healthcare provider and verify that any telehealth platform or clinic uses board-certified clinicians and accredited pharmacies.

:::

Sources